Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
CONCLUSIONS: These findings underscore the potential of plasma exosomal biomarkers for early NSCLC diagnosis and metastasis prediction. Notably, CFHR5 stands out as a promising prognostic indicator for NSCLC patients. The clinical utility of exosomal biomarkers offers the potential to enhance the management of NSCLC.PMID:37953280 | DOI:10.1186/s12575-023-00223-0
Source: Biological Procedures Online - Category: Molecular Biology Authors: Bin Luo Zujun Que Xinyi Lu Dan Qi Zhi Qiao Yun Yang Fangfang Qian Yi Jiang Yan Li Ronghu Ke Xiaoyun Shen Hua Xiao Hegen Li Erxi Wu Jianhui Tian Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Molecular Biology | Non-Small Cell Lung Cancer | Study